Cargando…
CTLA-4 immunotherapy exposes differences in immune response along with different tumor progression in colorectal cancer
Tumor growth is accompanied by a changing tumor microenvironment and mutations that increase the resistance to therapy. Here, we used syngeneic models to evaluate the drug response of tumors of the same type of different sizes. We used the in vivo efficacy and Ki-67 immunohistochemistry (IHC) assay...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467381/ https://www.ncbi.nlm.nih.gov/pubmed/32805718 http://dx.doi.org/10.18632/aging.103765 |